Board summary
Key figures
35,327
Registered population
58.0% aged 18–64
19.6%
Aged 65+
ICB 21.9% · England 17.9%
7.7%
Ethnic minority (non-White)
3.4% Asian · England 9.6%
0.0%
In IMD quintile 1
ICB 9.2% · England 21.0%
0
Core20 residents (est.)
Resident basis; registered basis 0 · see page 3
5,113
Hypertension register
+5.82% in 3 yrs · England +5.60%
272
SMI register
21.4% of Horsham's
441
COPD register
Reviews -2.91% in 3 yrs
Forecast to 2030
6,211
Hypertension patients, 2030
+1,098 on today
72.1%
QRISK ≥20% on statins, 2030
+4.43pp over 3 yrs
4.8%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Dementia prevalence fell while comparators rose.
Recorded dementia prevalence is 0.5% (Horsham 0.9%, England 0.8%) and changed -8.0% over 2023 to 2025 (England +6.0%), which may reflect unverified coding gaps.
Wide practice variation in telephony and immunisation.
Easy phone contact spans 41.5 pp (The Courtyard Surgery 40.1%, Cowfold Surgery 81.6%) and QOF vaccination achievement spans 47.2 pp, testable by practice audits.
Blood pressure and SMI checks exceed England.
Blood pressure control under 80 reaches 75.6% (Horsham 71.5%, England 67.8%), and SMI blood pressure checks reach 85.9% (England 83.4%).
Population, age and ethnicity
Children comprise 22.4% of registered patients alongside 951 catchment care home beds
Among 35,327 registered patients, children aged 0-17 comprise 22.4% (7,910), higher than Horsham (18.7%), NHS Sussex Integrated Care Board (17.7%) and England (19.6%). Conversely, patients aged 65+ account for 19.6% (6,919), below Horsham (23.7%) and the ICB (21.9%), but above England (17.9%). Local Census usual residents are 92.3% White (Horsham 93.6%, ICB 91.0%, England 81.1%), indicating a 7.7% ethnic minority share. Primary care list size is projected to expand 5.3% by 2030 (Horsham 4.4%, ICB 2.1%, England 2.3%) under unverified methodology. Note that Census ethnicity describes area residents rather than practice-confirmed registrations.
Age profile
65+: ICB 21.9%, England 17.9%
Ethnicity
Older people · falls rows are Horsham local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Horsham LA) | 2,154 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 88.4% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 60.8% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Horsham LA) | 909 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Horsham LA) | 10.5 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Average IMD decile is 8.2 with 0.0% Core20 registered patients across all practices
The PCN has an average IMD decile of 8.2, in line with Horsham (8.2 decile) and above NHS Sussex Integrated Care Board (6.1 decile) and England (5.5 decile). The Core20 cohort is 0.0% (0 patients), matching Horsham (0.0%) but below NHS Sussex Integrated Care Board (9.2%) and England (21.0%). Across 61 associated areas, Cowfold Surgery, Rudgwick Medical Centre, The Courtyard Surgery, and Village Surgery each record 0.0% Core20 patients. With zero Core20 areas, local health inequality work focuses on clinical inclusion cohorts rather than area-based deprivation.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
272
SMI register
0.75% recorded prevalence
142
Learning disability register
0.39% recorded prevalence
23
Care homes, 951 beds
In the PCN catchment
8.0%
Provide unpaid care
Horsham, Census 2021
Recorded learning disability prevalence is 0.4% (142 patients) and severe mental illness is 0.8% (272), both below England (0.6% and 1.0%). Catchment care homes provide 951 beds across 23 sites. District snapshot data records 9 rough sleepers, alongside an estimated ceiling of about 2,800 unpaid carers. Lower recorded prevalence across inclusion registers does not establish unmet need, but local register searches could verify diagnostic identification.
Severe mental illness: physical health checks
Recorded SMI blood pressure checks reached 85.9% (England 83.4%) and BMI checks reached 89.3% (England 82.1%). However, smoking cessation offers fell 2.3 pp (England +0.1 pp) to 91.7% (England 94.2%).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
5,113
Hypertension register
+5.82%
Register growth, 3 yrs
Horsham +4.65% · England +5.60%
+5.01pp
BP control, under 80
≤140/90 · +3.95pp aged 80+
+1,098
More patients by 2030
Forecast 6,211 (15.84%)
Hypertension case-finding and control
Recorded hypertension prevalence is 14.2% (5,113 patients), below Horsham (16.8%), NHS Sussex ICB (16.3%) and England (15.2%), varying locally from 12.3% at The Courtyard Surgery to 16.8% at Cowfold Surgery. This lower crude rate is consistent with a younger list (19.6% aged 65+ vs Horsham 23.7%), though observation periods were not supplied. Clinical processes are strong: 94.5% had a recent blood pressure check (England 90.0%), and 77.4% were treated to target (England 70.3%), with blood pressure control under 80 reaching 75.6% (England 67.8%). Lower crude prevalence alongside high treatment control could reflect demographic composition or case-finding variation across practices.
Lipids and statins
Patients with QRISK ≥ 20% on lipid-lowering therapy reached 62.2%, below England (63.6%) but above NHS Sussex ICB (60.0%). Lipid-regulating prescribing was 1,694 items per 1,000 adults, below England (4,100). Lower prescribing rates than England may warrant clinical review of primary prevention initiation.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 46,431 | £2.50 | £2.42 | £1.86 | £116,078 |
| Cardiovascular (all), 2025 | 57,819 | £4.42 | £3.32 | £3.33 | £255,560 |
In 2026, lipid-modifying drugs cost £2.50 per item across 46,431 items, compared with £1.86 in England, £2.42 in NHS Sussex ICB and £2.64 in Horsham. This unit cost represents £29,716 more than at England's unit cost. This unit-cost indicator does not establish inefficient prescribing, but could prompt review of lipid-modifying formulary choices.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+12.27%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
−0.39%
Asthma prevalence, PCN 3-yr % change
Asthma review coverage rose 12.3% over 2023 to 2025 (England +4.4%) to 65.3% (England 65.7%), leaving about 760 unreviewed patients across a register of 2,205. For patients aged 5-19, asthma management prescribing was 774 items per 1,000 (England 1,488). COPD recorded prevalence is 1.2% (441 patients; England 1.9%), implying an unadjusted gap of +83 to +228 patients. Although COPD reviews reached 79.6% (England 76.4%), coverage fell 2.9% over 2023 to 2025 (England +2.8%).
Cancer register and children's immunisation
Cancer register prevalence is 3.9% (1,396 patients), in line with England (3.8%). In Q1 2025/26, MMR1 coverage at age 5 reached 96.0%, exceeding the 95.0% target. However, MMR2 was 10.9 pp lower at 85.1% (9.9 pp below target), and the 4-in-1 pre-school booster reached 83.2% (11.8 pp below target). This drop-off could reflect call-recall attrition that local practice reviews could verify.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
58.5%
Sussex ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,360
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Sussex ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 56.6% | 53.2% | 19% | 1,668 |
| Breast | 86.1% | 85.4% | 23% | 1,400 |
| Bowel | 49.8% | 47.0% | 26% | 1,133 |
| Lung | 30.3% | 33.8% | 15% | 1,058 |
| Skin cancer | 95.3% | 87.8% | 17% | 698 |
Across NHS Sussex ICB in 2022, 58.5% of cancers with a known stage (4,799 of 8,209) were diagnosed at stage 1 or 2, above England (55.3%) but 16.5 pp below the 75.0% national ambition by 2028. ICB staging completeness was 64.3% (8,209 of 12,766 registered cancers). Sizing this gap indicates about 1,360 additional early-stage cases annually would be needed across the ICB. These ICB figures reflect wider system staging rather than PCN performance. At PCN level, breast screening coverage was 71.6% (Horsham 73.4%, England 69.9%), with 3-year change of -0.04% over 2023 to 2024 (England +8.4%), while practice coverage was 67.8% at The Courtyard Surgery.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In provisional July 2026 data, provider Surrey and Sussex Healthcare NHS Trust achieved 70.0% on the cancer 62-day standard, below the 85.0% standard, NHS Surrey and Sussex ICB (71.5%) and England (71.2%), while Royal Surrey NHS Foundation Trust reached 84.5% and University Hospitals Sussex NHS Foundation Trust achieved 65.2%. Faster diagnosis (28-day) reached 77.7% (standard 75.0%). Trust 6-week diagnostic waits were 28.5% across all tests (England 23.1%), with non-obstetric ultrasound at 32.3% and echocardiography at 43.8%. These figures describe wider acute system performance rather than PCN delivery.
| Pathways within standard (%) | Surrey and Sussex Healthcare | Sussex | Royal Surrey | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 77.74 | 74.01 | 82.62 | 79.29 | 79.32 |
| 31-day treatment (96%) | 96.20 | 76.79 | 96.43 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 69.97 | 65.20 | 84.48 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Surrey and Sussex Healthcare | Sussex | Royal Surrey | England |
|---|---|---|---|---|
| MRI | 27.53 | 5.62 | 0.00 | 21.40 |
| CT | 18.49 | 8.57 | 0.15 | 9.92 |
| Echocardiography | 43.78 | 0.39 | 1.55 | 28.48 |
| Colonoscopy | 15.11 | 39.35 | 0.00 | 30.83 |
| Gastroscopy | 21.06 | 20.02 | 0.00 | 29.02 |
| All 15 DM01 tests | 28.50 | 12.95 | 8.82 | 23.14 |
| Community services activity | West Sussex residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 78,050 | 309,615 |
| Referrals | 16,015 | 66,930 |
| Patients with a contact | 19,770 | 85,660 |
Community services (residents of West Sussex), Jun 2026 (provisional). Provisional community services data for June 2026 shows 72.7% of contacts among Horsham borough residents were for adults aged 65 and over (56,740 of 78,050 contacts). This local authority measure describes wider community service use rather than PCN-level activity.
Practice variation and patient experience
Practice phone access varies by 41.5 pp and vaccination achievement spans 47.2 pp
In 2025/26, overall QOF achievement ranged from 88.9% at The Courtyard Surgery to 97.7% at Rudgwick Medical Centre. Vaccination and immunisation achievement showed a 47.2 pp span, from 32.4% at The Courtyard Surgery to 79.5% at Rudgwick Medical Centre (England 55.2%). High overall points may conceal specific domain disparities that local reviews could verify.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Cowfold Surgery | 120 | 0.0 | 81.6% | 70.0% | 86.7% |
| Village Surgery | 117 | 0.0 | 70.4% | 65.8% | 78.8% |
| Rudgwick | 109 | 0.0 | 63.6% | 60.0% | 70.7% |
| Courtyard | 107 | 0.0 | 40.1% | 55.7% | 65.9% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Dementia QOF prevalence fell 8.0% against a +6.0% rise across England
Dementia QOF prevalence fell 8.0% over 2023 to 2025, trailing England (+6.0%), Horsham (+0.1%) and NHS Sussex Integrated Care Board (+2.2%). Breast screening coverage fell 0.04% (England +8.4%), and COPD reviews fell 2.9% (England +2.8%). Conversely, asthma reviews grew 12.3% (England +4.4%), and severe mental illness blood pressure checks increased 8.7 pp (England +4.4 pp) to 85.9%. This pattern is consistent with effective review processes alongside possible case-finding gaps that local searches could verify.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Dementia register
Breast screening (53-70)
COPD reviews
Diabetes HbA1c control
Learning disability register
Asthma reviews
BP check (SMI)
BP control, under 80
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Horsham | Asset | PCN | Horsham |
|---|---|---|---|---|---|
| Care homes (catchment) | 23 (951 beds) | n/a | Schools (catchment) | 67 | n/a |
| Children's centres | 6 | 9 | Places of worship | 56 | 93 |
| Libraries | 2 | 7 | Homelessness support (VCS) | 0 | no data |
| Day centres (VCS) | 5 | 7 | Children and young people (VCS) | n/a | 1 |
| Carers support groups (VCS) | 1 | 2 | Primary schools (LA maintained) | 25 | 37 |
| Primary academies | 5 | 6 | Special schools | 3 | 3 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
COPD case-finding and review recall
Recorded COPD prevalence is 1.2% (441 patients) versus 1.5% in Horsham and 1.9% in England (+83 to +228 range), while annual review coverage fell 2.9% over 2023 to 2025 (England +2.8%). Moderate effort to run.
Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.
Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.
Option 2
Dementia register coding and care-home check
Dementia prevalence is 0.5% (190 patients) against 0.9% in Horsham and 0.8% in England (+86 to +140 range), after falling 8.0% over 2023 to 2025 (England +6.0%). Low cost, quick to run.
Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.
Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.
Option 3
Learning disability register validation
Learning disability prevalence is 0.4% (142 patients) compared with 0.5% in Horsham and 0.6% in England (+35 to +66 range), with +2.9% three-year growth trailing England (+5.4%). For discussion, practices could validate learning disability registers by checking diagnostic codes and cross-referencing with social-care or education records where data sharing permits. Low cost, quick to run.
Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.
Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Inclusion health case finding (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| Smoking cessation offer audit (p4) | Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs) | MHIS · From Harm to Hope | PCN |
| Hypertension case finding audit (p5) | Hypertension: QOF prevalence | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school booster recall audit (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Breast screening recall audit (p7) | Breast screening coverage: aged 53 to 70 years old | — | PCN |
| Telephony access workflow review (p9) | GPPS good overall experience of the practice | 10YHP, hospital to community | Practice |
| Option 1 · COPD case-finding and review recall (p12) | COPD register · COPD: QOF prevalence · COPD patients with a review in the last 12 months | Core20PLUS5 approach · Tobacco and Vapes Bill | PCN |
| Option 2 · Dementia register coding and care-home check (p12) | Dementia register · Dementia: QOF prevalence · Aged 65+ | 66.7% diagnosis ambition · 95% care plan 2027 | PCN |
| Option 3 · Learning disability register validation (p12) | Learning disability register · Learning disability: QOF prevalence · Registered population | 75% annual health checks (Network Contract DES) · Oliver McGowan | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
